DexCom Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
88.36 M |
Public Float |
77.07 M |
DexCom Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.47 |
Market Cap |
$13.38 B |
Shares Outstanding |
91.05 M |
Public Float |
88.13 M |
Address |
6340 Sequence Drive San Diego California 92121 United States |
Employees | - |
Website | http://www.dexcom.com |
Updated | 07/08/2019 |
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps. The company was founded by John F. |